Clinical Trial Update: DLBS1033 Treatment in Diabetic With Peripheral Arterial Disease [Phase 2, Phase 3]

View source ↗

Summary

The DLBS1033 trial in patients with diabetes and peripheral arterial disease has been terminated during Phase 2/3.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetes Mellitus
• Peripheral Arterial Disease

Drugs mentioned

• DLBS1033 (DLBS1033)

Snippet

Sponsor: Dexa Medica Group | Conditions: Diabetes, Peripheral Arterial Disease | Phase 2, Phase 3 | Status: TERMINATED